These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33017455)

  • 1. Molecular diagnosis, genetic diversity and drug sensitivity patterns of Mycobacterium tuberculosis strains isolated from tuberculous meningitis patients at a tertiary care hospital in South India.
    Krishnakumariamma K; Ellappan K; Muthuraj M; Tamilarasu K; Kumar SV; Joseph NM
    PLoS One; 2020; 15(10):e0240257. PubMed ID: 33017455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the Diagnostic Utility of GeneXpert Mycobacterium tuberculosis/Rifampicin (MTB/RIF) Assay in the Suspected Cases of Tuberculous Meningitis.
    Patel S; Dadheech M; Maurya AK; Singh J; Purwar S; Rai N; Sarawagi R; Joshi A; Khadanga S
    Cureus; 2023 Apr; 15(4):e37761. PubMed ID: 37213979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis.
    Nhu NT; Heemskerk D; Thu do DA; Chau TT; Mai NT; Nghia HD; Loc PP; Ha DT; Merson L; Thinh TT; Day J; Chau Nv; Wolbers M; Farrar J; Caws M
    J Clin Microbiol; 2014 Jan; 52(1):226-33. PubMed ID: 24197880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis.
    Metcalf T; Soria J; Montano SM; Ticona E; Evans CA; Huaroto L; Kasper M; Ramos ES; Mori N; Jittamala P; Chotivanich K; Chavez IF; Singhasivanon P; Pukrittayakamee S; Zunt JR
    PLoS One; 2018; 13(6):e0198695. PubMed ID: 29912907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed
    Wang W; Liu R; Yao C; Huo F; Shang Y; Zhang X; Wang Y; Xue Z; Ma L; Pang Y
    Microbiol Spectr; 2022 Feb; 10(1):e0208721. PubMed ID: 35107324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
    Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
    BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic usefulness of Xpert MTB/RIF assay for detection of tuberculous meningitis using cerebrospinal fluid.
    Rufai SB; Singh A; Singh J; Kumar P; Sankar MM; Singh S;
    J Infect; 2017 Aug; 75(2):125-131. PubMed ID: 28501491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid and rifampicin heteroresistant Mycobacterium tuberculosis isolated from tuberculous meningitis patients in India.
    Gupta R; Thakur R; Kushwaha S; Jalan N; Rawat P; Gupta P; Aggarwal A; Gupta M; Manchanda V
    Indian J Tuberc; 2018 Jan; 65(1):52-56. PubMed ID: 29332649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of Xpert MTB/RIF assay with multiplex polymerase chain reaction for the diagnosis of tuberculous meningitis.
    Sharma K; Sharma M; Chaudhary L; Modi M; Goyal M; Sharma N; Sharma A; Jain A; Dhibar DP; Jain K; Khandelwal N; Ray P; Lal V; Salfinger M
    Tuberculosis (Edinb); 2018 Dec; 113():38-42. PubMed ID: 30514512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda.
    Komakech K; Nakiyingi L; Fred A; Achan B; Joloba M; Kirenga BJ; Ssengooba W
    BMC Infect Dis; 2024 Jan; 24(1):70. PubMed ID: 38200467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant
    He G; Zheng Q; Wu J; Wu L; Geng Z; Jiang G; Huang H; Jiang X; Yu X
    Microbiol Spectr; 2024 Jun; 12(6):e0385923. PubMed ID: 38738892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid detection of extensively drug-resistant (XDR-TB) strains from multidrug-resistant tuberculosis (MDR-TB) cases isolated from smear-negative pulmonary samples in an Intermediate Reference Laboratory in India.
    Vashistha H; Hanif M; Saini S; Khanna A; Sharma S; Sidiq Z; Ahmed V; Dubey M; Chopra KK; Shrivastava D
    Indian J Tuberc; 2016 Jul; 63(3):144-148. PubMed ID: 27865234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling and identification of novel rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Pakistan.
    Qadir M; Tahseen S; McHugh TD; Hussain A; Masood F; Ahmed N; Faryal R
    J Infect Chemother; 2021 Nov; 27(11):1578-1583. PubMed ID: 34244055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis.
    Rahman A; Sahrin M; Afrin S; Earley K; Ahmed S; Rahman SM; Banu S
    PLoS One; 2016; 11(4):e0152694. PubMed ID: 27054344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Anyplex™ II MTB/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens.
    Chumpa N; Kawkitinarong K; Rotcheewaphan S; Sawatpanich A; Petsong S; Tumwasorn S; Suwanpimolkul G
    Mol Biol Rep; 2020 Apr; 47(4):2501-2508. PubMed ID: 32124172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting.
    Yoo IY; Huh HJ; Kang OK; Jhun BW; Koh WJ; Lee NY
    Respir Med; 2019 Jan; 146():71-75. PubMed ID: 30665521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.